Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Targeted sleep care during tobacco or cannabis quitting

Official title: Impact of an Intervention Targeting Sleep Disorders During Tobacco or Cannabis Cessation Therapy: a Randomised Pilot Study

Run by Centre Hospitalier St Anne · NCT07202351 · Data updated 2026-11-12

This pilot will test whether systematically screening for and treating sleep problems during quitting programs helps adults stopping tobacco or cannabis stay abstinent longer.

More Sleep Disorder trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment80 (estimated)
SponsorCentre Hospitalier St Anne
Academic / other
Locations1 site (Paris, Île-de-France Region)
StatusRecruiting
StartedJune 5, 2023
Main results expectedFebruary 27, 2026
Study endsAugust 31, 2026
Registry record updatedOctober 1, 2025
Trial IDNCT07202351 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (18+) seeking tobacco or cannabis cessation at the participating Paris addiction centres who are covered by French health insurance and willing to accept additional sleep screening and referral are ideal candidates.

Probably not a fit

People already receiving treatment for sleep disorders, hospitalized during cessation, diagnosed with psychotic disorders, participating in another study, or who decline the additional intervention are unlikely to benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

In a randomized pilot at two addiction care centres in Paris, adults seeking help to quit tobacco or cannabis will be assigned to usual multidisciplinary care or to the same care plus systematic sleep disorder screening. Patients in the intervention arm who screen positive will be referred to the Chronos centre for targeted sleep management. The trial will follow participants over six months with scheduled clinic visits to track sleep symptoms and substance abstinence. The primary aim is to see if identifying and managing sleep disorders reduces relapse during cessation treatment.

Why it matters

Potential benefit: If successful, this approach could lower relapse rates and improve sleep quality for people trying to quit tobacco or cannabis.

How similar studies have gone: Previous research has linked sleep problems to relapse and some sleep-focused interventions have shown promise, but systematic targeted management during cessation remains relatively untested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* patients over 18 years old
* presenting at the participating addiction treatment centres for a smoking or cabannis use cessation therapy
* who agree to participate to the study
* affiliated to the French health insurance system

Exclusion Criteria:

* Patients hospitalised during the cessation therapy
* Patients undergoing sleep disorders treatment
* Patients participating to another study
* Patients with psychotic disorders (according the DSM-5 classification)
* Patients who do not want the additionnal intervention and care if randomised in the intervention group

Where it's running

  • GHU Paris Psychiatrie et Neurosciences
    Paris, Île-de-France Region, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.